Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
Phase 2 Study of Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
-
Clinical Trial Information
Trial Contact: Dubberly, Paige D; Armatti, Julie M; Parker, Melanie; Doyle, Katherine M; Spinelli, Jennifer
Trial Phone: 321-841-7561 ; 321-843-5284 ; 321-843-1036 ; 3218412008 ; 321.841.5357
-
IRB No: 23.112.06
Protocol Abbrev: SJiMB21
Principal Investigator: Ana Eugenia Aguilar Bonilla, MD
Phase: Drug: Phase II
Age Group: Pediatric
ClinicalTrials.gov ID: NCT05535166
-
Objective
XXXXX
